New scan could reveal which plaques lead to stroke
NCT ID NCT02726984
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a special PET/MR scan using a radioactive tracer called 18F-sodium fluoride to see if it can better identify dangerous carotid artery plaques. The researchers compared 6 patients who recently had a stroke with 6 who had no symptoms, all with significant plaque buildup. The goal was to see if the scan could spot signs of plaque vulnerability that might predict future strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-sodium fluoride (a radioactive tracer injected for imaging)
What this could lead to
If successful, this imaging technique could help doctors identify which carotid plaques are most likely to cause a stroke, guiding treatment decisions.
What could go wrong
This is a very small pilot study with only 15 participants, so results may not apply broadly. The imaging method is experimental and not yet proven to improve patient outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAROTID ARTERY PLAQUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospices Civils de Lyon
Bron, 69500, France